课题基金 / 基金详情

TRANSLATION INHIBITORS OF HEPATITIS C VIRUS

TRANSLATION INHIBITORS OF HEPATITIS C VIRUS
丙型肝炎病毒的翻译抑制剂
批准号:
6286430
负责人:
ASIM DASGUPTA
金额:
$4.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-30 至 2000-09-29

项目摘要

项目成果

ASIM DASGUPTA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The long term objective of this proposal is to develop novel antiviral drugs effective against hepatitis C virus (HCV). HCV infection in humans leads to progressive destruction of the liver resulting in cirrhosis and heightened risk of hepatocellular carcinoma. Antiviral drugs (such as interferon) have had limited success in controlling HCV-induced liver disease. Two novel molecules have been discovered both of which block HCV protein synthesis without adversely affecting the host cell. This proposal will examine direct and liposome-mediated delivery of these molecules individually and in combination to the liver of experimental animals. In addition, distribution, stability and clearance of these molecules in liver and various other organs of mice will be determined. If successful, the efficacy of these molecules in blocking HCV infection can be studied in chimpanzees. It is hoped that the experiments proposed here will lead to development of novel antiviral drugs effective against HCV infection in humans. PROPOSED COMMERCIAL APPLICATION The experiments proposed here should yield important information leading to development of novel drugs effective against HCV infection in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of hepatitis C virus 5' untranslated region in virus morphogenesis
The role of hepatitis C virus 5' untranslated region in virus morphogenesis
Towards Developing type 1a HCV cell culture model
Towards Developing type 1a HCV cell culture model
海外基金